Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
DCVC, also known as Data Collective, is a venture capital firm founded over 15 years ago, with offices in Palo Alto and San Francisco, California. The firm focuses on backing entrepreneurs who leverage computational approaches to address significant global challenges across various industries. DCVC manages approximately $4 billion in assets under management (AUM) and operates multiple funds, including specialized funds like DCVC Bio, which concentrates on computational biology and life sciences.
Over the years, DCVC has established itself as a key player in the deep tech investment space, supporting companies that utilize artificial intelligence and advanced technologies. The firm has a diverse portfolio that includes notable companies such as Fervo Energy, Latus Bio, and Pivot Bio, indicating a robust investment strategy aimed at addressing high-stakes problems across sectors like energy, biotechnology, and machine learning.
DCVC invests in deep tech companies that utilize artificial intelligence to tackle high-stakes problems across various sectors. The firm focuses on industries such as energy, biotechnology, climate change, human health, industrial transformation, defense, and security. Investment stages range from pre-seed to growth equity, allowing DCVC to support entrepreneurs at different phases of their development.
The firm seeks to partner with companies that are addressing complex global challenges through innovative solutions. DCVC is particularly interested in startups that leverage computational approaches to unlock potential in their respective fields. Check sizes typically vary based on the stage of investment, aligning with the firm's commitment to supporting transformative technologies.
DCVC's portfolio includes several notable companies that exemplify its focus on deep tech and AI-driven solutions:
These companies reflect DCVC's commitment to investing in technologies that address significant global challenges, particularly in the deep tech sector.
Zachary Bogue: Co-Founder and Managing Partner. He has a background in technology and venture capital, with experience in leading investments in deep tech companies.
Matthew Ocko: Co-Founder and Managing Partner. He specializes in investments in AI and machine learning, with a focus on transformative technologies.
Dr. John Hamer: Managing Partner, DCVC Bio. He has expertise in computational biology and has led investments in life sciences.
Dr. Kiersten Stead: Managing Partner, DCVC Bio. She focuses on biotechnology investments and has a strong background in research and development.
Spencer Punter: Partner & COO. He oversees operations and has experience in scaling startups.
Alan Cohen: General Partner. He has a history of successful investments in various sectors, including energy and technology.
James Hardiman: General Partner. He specializes in investments in deep tech and has a strong analytical background.
Jason Pontin: General Partner. He has experience in media and technology, focusing on innovative startups.
Dr. Rachel Slaybaugh: General Partner. She has expertise in energy technologies and has led investments in sustainable solutions.
Ali Tamaseb: General Partner. He focuses on AI-driven startups and has a background in engineering and technology.
Milo Werner: General Partner. He specializes in investments in emerging technologies and has a strong entrepreneurial background.
To pitch DCVC, founders should visit their website at dcvc.com. A well-structured pitch deck should include details about the technology, market opportunity, team background, and financial projections. DCVC prefers pitches that demonstrate a clear understanding of the problem being solved and the potential impact of the solution. Response times may vary, but founders are encouraged to follow up if they do not receive a timely response.
DCVC operates various funds and initiatives, including:
In recent months, DCVC has made several notable investments in deep tech companies, further expanding its portfolio. The firm continues to support innovative startups that address significant global challenges, particularly in the areas of energy and biotechnology.
DCVC has also participated in industry conferences, including the World Economic Forum and New York Climate Week, showcasing its commitment to addressing climate-related challenges through technology.
What are DCVC's investment criteria?
DCVC invests in deep tech companies that leverage artificial intelligence and other advanced technologies to solve high-stakes problems across various sectors, including energy, biotechnology, and climate change.
How can I pitch to DCVC?
Founders can pitch to DCVC through their website at dcvc.com. It is recommended to include a clear explanation of the technology, market opportunity, and team in the pitch deck.
What makes DCVC different from other venture capital firms?
DCVC focuses specifically on deep tech and AI-driven solutions, investing in companies that address complex global challenges. Their specialized funds, such as DCVC Bio, allow for targeted investments in specific sectors.
What is the geographic scope of DCVC's investments?
DCVC primarily invests in companies based in the United States, although they may consider international opportunities that align with their investment thesis.
What is DCVC's post-investment involvement like?
DCVC actively supports its portfolio companies through mentorship, operational support, and access to their extensive network in the deep tech ecosystem. They often participate in board meetings and provide follow-on investment when appropriate.
What is the typical check size for investments?
Check sizes vary based on the stage of investment, ranging from pre-seed to growth equity, allowing DCVC to tailor their financial support to the needs of each startup.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.